U.S. to spend $ 3.2Bn to develop treatments for COVID-19

The United States has announced that it will spend $ 3.2 billion on developing antiviral treatments for COVID-19 and prepare for other “pandemic threats” – viruses that have the potential to cause pandemics.“Vaccines will continue to remain the ‘centrepiece of our arsenal’ against COVID-19,” Anthony Fauci, medical advisor to the U.S. President, said on Thursday, when he described the programme, called the Antiviral Program for Pandemics.
“However, antivirals can and are an important complement to existing vaccines, especially for individuals with certain conditions that might put them at a greater risk,” he said. “And it also adds a line of defence against other unexpected emerging things, like variants of concern that we are currently dealing with…,”he added.